These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18626477)

  • 1. A paradigm shift in the mechanisms of graft rejection.
    Zell D; Hu S; Kirsner RS
    J Invest Dermatol; 2008 Aug; 128(8):1874. PubMed ID: 18626477
    [No Abstract]   [Full Text] [Related]  

  • 2. Langerhans cells are not required for efficient skin graft rejection.
    Obhrai JS; Oberbarnscheidt M; Zhang N; Mueller DL; Shlomchik WD; Lakkis FG; Shlomchik MJ; Kaplan DH
    J Invest Dermatol; 2008 Aug; 128(8):1950-5. PubMed ID: 18337832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ia antigens and epidermal Langerhans cells.
    Streilein JW; Bergstresser PR
    Transplantation; 1980 Nov; 30(5):319-23. PubMed ID: 7006163
    [No Abstract]   [Full Text] [Related]  

  • 4. Langerhans cell dogma: another round of rejections.
    Udey MC; Rosenberg AS
    J Invest Dermatol; 2008 Aug; 128(8):1881-3. PubMed ID: 18626480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of IA antigen+ epidermal cells in rejection of rat skin equivalent grafts.
    Lerner-Tung MB; Hull BE
    Transplantation; 1990 Jun; 49(6):1181-4. PubMed ID: 2163135
    [No Abstract]   [Full Text] [Related]  

  • 6. Is delayed-type hypersensitivity the pathway of hyperacute rejection in transplanted mouse hearts?
    Eichwald EJ; Shelby J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):426-7. PubMed ID: 3274798
    [No Abstract]   [Full Text] [Related]  

  • 7. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction.
    Rosenberg AS; Singer A
    Annu Rev Immunol; 1992; 10():333-58. PubMed ID: 1590990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice.
    Valujskikh A; Matesic D; Gilliam A; Anthony D; Haqqi TM; Heeger PS
    J Clin Invest; 1998 Mar; 101(6):1398-407. PubMed ID: 9502782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin allografts--lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model.
    Galkowska H; Olszewski WL; Moscicka M; Cybulska E; Ziolkowska A; Wojewodzka U; Mijal J
    Ann Transplant; 1999; 4(3-4):5-10. PubMed ID: 10853773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cultured epithelium allografts: Langerhans cell and Thy-1+ dendritic epidermal cell depletion effects on allograft rejection.
    Rouabhia M; Germain L; Bélanger F; Auger FA
    Transplantation; 1993 Aug; 56(2):259-64. PubMed ID: 8102819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties.
    Bergstresser PR; Fletcher CR; Streilein JW
    J Invest Dermatol; 1980 Feb; 74(2):77-80. PubMed ID: 6985948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal.
    Dunn LA; Evander M; Tindle RW; Bulloch AL; de Kluyver RL; Fernando GJ; Lambert PF; Frazer IH
    Virology; 1997 Aug; 235(1):94-103. PubMed ID: 9300040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody production and skin graft rejection.
    Nature; 1972 Jul; 238(5358):16. PubMed ID: 12635258
    [No Abstract]   [Full Text] [Related]  

  • 18. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
    Wecker H; Grusby MJ; Auchincloss H
    Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.
    Loveland BE; McKenzie IF
    Immunology; 1982 Jun; 46(2):313-20. PubMed ID: 7044959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.